Pediatrix Medical Group, Inc. (MD) Q2 2024 Earnings Call Transcript

SA Transcripts
153.96K Followers

Q2: 2024-08-06 Earnings Summary

EPS of $0.34 beats by $0.03
 | Revenue of $504.30M (0.74% Y/Y) misses by $705.40K

Pediatrix Medical Group, Inc. (NYSE:MD) Q2 2024 Earnings Conference Call August 6, 2024 9:00 AM ET

Company Participants

Charles Lynch - SVP, Finance & Strategy
Jim Swift - CEO
Marc Richards - CFO
Kasandra Rossi - SVP, Financial Reporting & Assistant Treasurer

Conference Call Participants

A.J. Rice - UBS
Nur Robleh - Jefferies
Benjamin Shaver - Deutsche Bank
Kevin Fischbeck - Bank of America

Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Pediatrix Medical Group 2024 Second Quarter Earnings Conference Call. At this time, all participants' lines are in a listen-only mode. [Operator Instructions]. As a reminder, this conference is being recorded.

I'd now like to turn the conference over to Charles Lynch. Please go ahead.

Charles Lynch

Thank you, operator, and good morning, everyone.

I'm going to quickly read our forward-looking statements before we begin the call. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995.

These forward-looking statements are based on assumptions and assessments made by Pediatrix management in light of their experience and assessment of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate. Any forward-looking statements made during this call are made as of today and Pediatrix undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise.

Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements, are described in the company's filings with the SEC, including the sections entitled "Risk Factors".

In today's remarks by management, we will be discussing non-GAAP financial metrics. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measures can be found in

Recommended For You

About MD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on MD